VCA-1612

N/A

Report date: 2025/01/26 15:40:33

Base Information

Drug NameVCA-1612
Drug Alias Nameoncolytic virus therapy (Virica)VCA-1612
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVirica Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesVirica Biotech Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A